Shanghai, China
Charles River Laboratories opened its 60,000-sf preclinical facility in Shanghai in October of 2008. The drug development building will begin providing GLP (Good Laboratory Practice) biopharmaceutical research and development services in the first quarter of 2009. The project includes vivarium facilities for animal research and will comply with AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care) and U.S. FDA guidelines.
